Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Barnegat fixed income relative value hedge fund up 6% YTD, annualises 19% since 2001 inception

Friday, April 05, 2013

amb
Bob Treue
Benedicte Gravrand, Opalesque Geneva:

The Barnegat Fund gained 1.9% in March 2013, and is up 6.3% year to date, annualising +19.6% since its 2001 inception. Annualized volatility of the share price was 6.5% for the month.

The $702m fixed income relative value hedge fund based out of New Jersey returned an impressive 406% during its first decade in business, earning acclaim as the top performing fixed-income relative-value hedge fund of the last ten years. When the fund completed its 11th year in February 2012, the share price had gone from 1.0000 to 6.0878, a gain of 508% (annualising 17.8%).

Barnegat focuses on interest-rate anomalies in the large, liquid markets of North America, Europe and the Pacific Rim. It captures these mispricings via government bonds, interest-rate swaps and futures.

Bob Treue, founder and CEO of the Barnegat Fund, commented in an e-mail received by Opalesque yesterday; "We are in a good spot based on government market interventions creating new trading opportunities while government regulatory rulings reduce our competition."

"Bank prop desks (our competition) continue to close, although some of those employees re-appear at other funds. From my limited view, Dodd-Frank and Volcker legislation have resulted in a net reduction in our competition," he added.

Treue started his experience in fixed......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner